Palisade Bio (PALI) Profit After Tax (2010 - 2026)
Palisade Bio's (PALI) quarterly Profit After Tax came in at -$9.6 million in Q1 2026, down 330.49% year-on-year from $4.2 million in Q1 2025, and down 7.88% on a QoQ basis from -$8.9 million in Q4 2025.
Palisade Bio (PALI) Profit After Tax (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Profit After Tax data on file, last reported at -$9.6 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 330.49% year-over-year to -$9.6 million in Q1 2026; TTM through Mar 2026 was -$24.2 million, a 83.78% decrease from a year earlier, with the FY2025 full-year figure at -$16.8 million, down 16.23% from the prior year.
- Profit After Tax for Q1 2026 stood at -$9.6 million, down from -$8.9 million in the prior quarter.
- Over the last five years, Profit After Tax for PALI reached as high as -$2.2 million in Q1 2025 and fell as low as -$9.6 million in Q1 2026.
- Historically, Profit After Tax has averaged -$4.0 million across 5 years, with a median of -$3.5 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 92.62% in 2022 and fell as far as 446.69% in 2022.
- Year by year, Profit After Tax stood at -$3.7 million in 2022, then gained by 20.13% to -$3.0 million in 2023, then slipped by 12.55% to -$3.3 million in 2024, then slumped by 166.12% to -$8.9 million in 2025, then dropped by 7.88% to -$9.6 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$9.6 million in Q1 2026, -$8.9 million in Q4 2025, and -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Palisade Bio | 413.04 Mn | 280.41 Mn | - | -9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.60 Mn |
| Dec 31, 2025 | -8.90 Mn |
| Sep 30, 2025 | -2.87 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Mar 31, 2025 | -2.23 Mn |
| Dec 31, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Mar 31, 2024 | -3.53 Mn |
| Dec 31, 2023 | -2.97 Mn |
| Sep 30, 2023 | -3.60 Mn |
| Jun 30, 2023 | -3.39 Mn |
| Mar 31, 2023 | -2.34 Mn |
| Dec 31, 2022 | -3.72 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | -2.34 Mn |
| Mar 31, 2022 | -4.21 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 8.09 Mn |
| Jun 30, 2021 | -31.75 Mn |